Correction: Formation of drug nanocrystals under nanoconfinement afforded by liposomes
Abstract
Correction for ‘Formation of drug nanocrystals under nanoconfinement afforded by liposomes’ by D. Cipolla et al., RSC Adv., 2016, 6, 6223–6233.
* Corresponding authors
a
Faculty of Pharmacy, The University of Sydney, Australia
E-mail:
dcip8510@uni.sydney.edu.au
b
Aradigm Corporation, Hayward, CA 94545, USA
E-mail:
cipollad@aradigm.com
c
Laboratory for Biointerfaces, Department Materials meet Life, Empa, Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland
E-mail:
stefan.salentinig@gmail.com
d Monash Institute of Pharmaceutical Sciences, Monash, Australia
e Department of Pharmaceutical Sciences, University of Copenhagen, Denmark
f Adolphe Merkle Institute, Université de Fribourg, Fribourg, Switzerland
g ProNAi Therapeutics, Vancouver, BC, Canada
h Northern Lipids Inc., Burnaby, Canada
Correction for ‘Formation of drug nanocrystals under nanoconfinement afforded by liposomes’ by D. Cipolla et al., RSC Adv., 2016, 6, 6223–6233.
D. Cipolla, H. Wu, S. Salentinig, B. Boyd, T. Rades, D. Vanhecke, A. Petri-Fink, B. Rothen-Rutishauser, S. Eastman, T. Redelmeier, I. Gonda and H. K. Chan, RSC Adv., 2016, 6, 12123 DOI: 10.1039/C6RA90006B
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content